BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17991554)

  • 1. Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma.
    Valdevenito JP; Gallegos I; Fernández C; Acevedo C; Palma R
    Urology; 2007 Oct; 70(4):777-80. PubMed ID: 17991554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intertubular growth in pure seminomas: associations with poor prognostic parameters.
    Browne TJ; Richie JP; Gilligan TD; Rubin MA
    Hum Pathol; 2005 Jun; 36(6):640-5. PubMed ID: 16021570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?
    Vogt AP; Chen Z; Osunkoya AO
    Hum Pathol; 2010 Sep; 41(9):1339-44. PubMed ID: 20573373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
    Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
    J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for biomarkers of metastatic seminoma.
    Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting metastasized seminoma using gene expression.
    Ruf CG; Linbecker M; Port M; Riecke A; Schmelz HU; Wagner W; Meineke V; Abend M
    BJU Int; 2012 Jul; 110(2 Pt 2):E14-20. PubMed ID: 22243760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry expression of P53, Ki67, CD30, and CD117 and presence of clinical metastasis at diagnosis of testicular seminoma.
    Gallegos I; Valdevenito JP; Miranda R; Fernandez C
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):147-52. PubMed ID: 20881837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological risk factors for higher clinical stage in testicular seminomas.
    Trevino KE; Esmaeili-Shandiz A; Saeed O; Xu H; Ulbright TM; Idrees MT
    Histopathology; 2018 Nov; 73(5):741-747. PubMed ID: 29858564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis.
    Schwartz BF; Auman R; Peretsman SJ; Moul JW; Deshon GE; Hernandez J; Rozanski RA; Thrasher JB
    J Surg Oncol; 1996 Feb; 61(2):131-3. PubMed ID: 8606544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.
    Choo R; Thomas G; Woo T; Lee D; Kong B; Iscoe N; Danjoux C; Klotz L; Morton G; Chander S
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):736-40. PubMed ID: 15708251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition.
    Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
    Hum Pathol; 2019 Dec; 94():16-22. PubMed ID: 31666197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
    Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
    Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermatocytic seminoma: a review.
    Chung PW; Bayley AJ; Sweet J; Jewett MA; Tew-George B; Gospodarowicz MK; Warde PR
    Eur Urol; 2004 Apr; 45(4):495-8. PubMed ID: 15041115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rete Testis Invasion Is Consistent With Pathologic Stage T1 in Germ Cell Tumors.
    Farooq A; Jorda M; Whittington E; Kryvenko ON; Braunhut BL; Pavan N; Procházková K; Zhang L; Rai S; Miller T; Liu J; Szabo A; Iczkowski KA
    Am J Clin Pathol; 2019 Apr; 151(5):479-485. PubMed ID: 30576407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
    Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
    Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited.
    Aparicio J
    Clin Transl Oncol; 2018 Oct; 20(10):1358-1359. PubMed ID: 29744734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.